nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Lisinopril—systemic scleroderma	0.117	0.328	CbGbCtD
Terazosin—ABCB1—Captopril—systemic scleroderma	0.0878	0.246	CbGbCtD
Terazosin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0692	0.193	CbGbCtD
Terazosin—ABCB1—Prednisone—systemic scleroderma	0.0553	0.155	CbGbCtD
Terazosin—ABCB1—Methotrexate—systemic scleroderma	0.0277	0.0776	CbGbCtD
Terazosin—Dyspepsia—Leflunomide—systemic scleroderma	0.000741	0.00115	CcSEcCtD
Terazosin—Vomiting—Mometasone—systemic scleroderma	0.00074	0.00115	CcSEcCtD
Terazosin—Dry mouth—Lisinopril—systemic scleroderma	0.000738	0.00115	CcSEcCtD
Terazosin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000735	0.00114	CcSEcCtD
Terazosin—Rash—Mometasone—systemic scleroderma	0.000734	0.00114	CcSEcCtD
Terazosin—Asthenia—Captopril—systemic scleroderma	0.000733	0.00114	CcSEcCtD
Terazosin—Dermatitis—Mometasone—systemic scleroderma	0.000733	0.00114	CcSEcCtD
Terazosin—Decreased appetite—Leflunomide—systemic scleroderma	0.000732	0.00114	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000732	0.00114	CcSEcCtD
Terazosin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000731	0.00114	CcSEcCtD
Terazosin—Confusional state—Lisinopril—systemic scleroderma	0.00073	0.00114	CcSEcCtD
Terazosin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000729	0.00114	CcSEcCtD
Terazosin—Headache—Mometasone—systemic scleroderma	0.000729	0.00113	CcSEcCtD
Terazosin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00113	CcSEcCtD
Terazosin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000727	0.00113	CcSEcCtD
Terazosin—Fatigue—Leflunomide—systemic scleroderma	0.000726	0.00113	CcSEcCtD
Terazosin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000724	0.00113	CcSEcCtD
Terazosin—Oedema—Lisinopril—systemic scleroderma	0.000724	0.00113	CcSEcCtD
Terazosin—Pruritus—Captopril—systemic scleroderma	0.000723	0.00113	CcSEcCtD
Terazosin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000722	0.00112	CcSEcCtD
Terazosin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00112	CcSEcCtD
Terazosin—Pain—Leflunomide—systemic scleroderma	0.00072	0.00112	CcSEcCtD
Terazosin—Constipation—Leflunomide—systemic scleroderma	0.00072	0.00112	CcSEcCtD
Terazosin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000716	0.00111	CcSEcCtD
Terazosin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000714	0.00111	CcSEcCtD
Terazosin—Shock—Lisinopril—systemic scleroderma	0.000712	0.00111	CcSEcCtD
Terazosin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00071	0.0011	CcSEcCtD
Terazosin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000709	0.0011	CcSEcCtD
Terazosin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000707	0.0011	CcSEcCtD
Terazosin—Tachycardia—Lisinopril—systemic scleroderma	0.000706	0.0011	CcSEcCtD
Terazosin—Body temperature increased—Azathioprine—systemic scleroderma	0.000705	0.0011	CcSEcCtD
Terazosin—Abdominal pain—Azathioprine—systemic scleroderma	0.000705	0.0011	CcSEcCtD
Terazosin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00109	CcSEcCtD
Terazosin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.0007	0.00109	CcSEcCtD
Terazosin—Diarrhoea—Captopril—systemic scleroderma	0.000699	0.00109	CcSEcCtD
Terazosin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000699	0.00109	CcSEcCtD
Terazosin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000698	0.00109	CcSEcCtD
Terazosin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00108	CcSEcCtD
Terazosin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000696	0.00108	CcSEcCtD
Terazosin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000694	0.00108	CcSEcCtD
Terazosin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000693	0.00108	CcSEcCtD
Terazosin—Nausea—Mometasone—systemic scleroderma	0.000691	0.00108	CcSEcCtD
Terazosin—Anorexia—Lisinopril—systemic scleroderma	0.00069	0.00107	CcSEcCtD
Terazosin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000689	0.00107	CcSEcCtD
Terazosin—Weight increased—Prednisone—systemic scleroderma	0.000688	0.00107	CcSEcCtD
Terazosin—Pain—Mycophenolic acid—systemic scleroderma	0.000687	0.00107	CcSEcCtD
Terazosin—Constipation—Mycophenolic acid—systemic scleroderma	0.000687	0.00107	CcSEcCtD
Terazosin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000687	0.00107	CcSEcCtD
Terazosin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000683	0.00106	CcSEcCtD
Terazosin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00106	CcSEcCtD
Terazosin—Hypotension—Lisinopril—systemic scleroderma	0.000676	0.00105	CcSEcCtD
Terazosin—Dizziness—Captopril—systemic scleroderma	0.000676	0.00105	CcSEcCtD
Terazosin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000673	0.00105	CcSEcCtD
Terazosin—Depression—Prednisone—systemic scleroderma	0.000672	0.00105	CcSEcCtD
Terazosin—Abdominal pain—Leflunomide—systemic scleroderma	0.000666	0.00104	CcSEcCtD
Terazosin—Body temperature increased—Leflunomide—systemic scleroderma	0.000666	0.00104	CcSEcCtD
Terazosin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000662	0.00103	CcSEcCtD
Terazosin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00103	CcSEcCtD
Terazosin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00103	CcSEcCtD
Terazosin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00103	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000659	0.00103	CcSEcCtD
Terazosin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000659	0.00103	CcSEcCtD
Terazosin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000657	0.00102	CcSEcCtD
Terazosin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000657	0.00102	CcSEcCtD
Terazosin—Insomnia—Lisinopril—systemic scleroderma	0.000655	0.00102	CcSEcCtD
Terazosin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000654	0.00102	CcSEcCtD
Terazosin—Paraesthesia—Lisinopril—systemic scleroderma	0.00065	0.00101	CcSEcCtD
Terazosin—Vomiting—Captopril—systemic scleroderma	0.00065	0.00101	CcSEcCtD
Terazosin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000647	0.00101	CcSEcCtD
Terazosin—Dyspnoea—Lisinopril—systemic scleroderma	0.000645	0.001	CcSEcCtD
Terazosin—Rash—Captopril—systemic scleroderma	0.000644	0.001	CcSEcCtD
Terazosin—Dermatitis—Captopril—systemic scleroderma	0.000644	0.001	CcSEcCtD
Terazosin—Somnolence—Lisinopril—systemic scleroderma	0.000643	0.001	CcSEcCtD
Terazosin—Headache—Captopril—systemic scleroderma	0.00064	0.000996	CcSEcCtD
Terazosin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000639	0.000995	CcSEcCtD
Terazosin—Dyspepsia—Lisinopril—systemic scleroderma	0.000637	0.000992	CcSEcCtD
Terazosin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000635	0.000989	CcSEcCtD
Terazosin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000635	0.000989	CcSEcCtD
Terazosin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000634	0.000987	CcSEcCtD
Terazosin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000634	0.000987	CcSEcCtD
Terazosin—Asthma—Methotrexate—systemic scleroderma	0.000632	0.000983	CcSEcCtD
Terazosin—Decreased appetite—Lisinopril—systemic scleroderma	0.000629	0.000979	CcSEcCtD
Terazosin—Fatigue—Lisinopril—systemic scleroderma	0.000624	0.000971	CcSEcCtD
Terazosin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000624	0.000971	CcSEcCtD
Terazosin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000966	CcSEcCtD
Terazosin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000621	0.000966	CcSEcCtD
Terazosin—Constipation—Lisinopril—systemic scleroderma	0.000619	0.000963	CcSEcCtD
Terazosin—Pain—Lisinopril—systemic scleroderma	0.000619	0.000963	CcSEcCtD
Terazosin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000619	0.000963	CcSEcCtD
Terazosin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000954	CcSEcCtD
Terazosin—Diarrhoea—Azathioprine—systemic scleroderma	0.00061	0.00095	CcSEcCtD
Terazosin—Nausea—Captopril—systemic scleroderma	0.000607	0.000945	CcSEcCtD
Terazosin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000605	0.000941	CcSEcCtD
Terazosin—Asthenia—Leflunomide—systemic scleroderma	0.000604	0.000941	CcSEcCtD
Terazosin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000596	0.000928	CcSEcCtD
Terazosin—Pruritus—Leflunomide—systemic scleroderma	0.000596	0.000927	CcSEcCtD
Terazosin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000922	CcSEcCtD
Terazosin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000592	0.000921	CcSEcCtD
Terazosin—Dysuria—Methotrexate—systemic scleroderma	0.000591	0.000919	CcSEcCtD
Terazosin—Dizziness—Azathioprine—systemic scleroderma	0.00059	0.000918	CcSEcCtD
Terazosin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000582	0.000906	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000578	0.000899	CcSEcCtD
Terazosin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000577	0.000897	CcSEcCtD
Terazosin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000577	0.000897	CcSEcCtD
Terazosin—Diarrhoea—Leflunomide—systemic scleroderma	0.000576	0.000897	CcSEcCtD
Terazosin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000893	CcSEcCtD
Terazosin—Abdominal pain—Lisinopril—systemic scleroderma	0.000572	0.00089	CcSEcCtD
Terazosin—Body temperature increased—Lisinopril—systemic scleroderma	0.000572	0.00089	CcSEcCtD
Terazosin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000886	CcSEcCtD
Terazosin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000569	0.000885	CcSEcCtD
Terazosin—Vomiting—Azathioprine—systemic scleroderma	0.000567	0.000883	CcSEcCtD
Terazosin—Eye disorder—Prednisone—systemic scleroderma	0.000565	0.00088	CcSEcCtD
Terazosin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00088	CcSEcCtD
Terazosin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000877	CcSEcCtD
Terazosin—Rash—Azathioprine—systemic scleroderma	0.000562	0.000875	CcSEcCtD
Terazosin—Dermatitis—Azathioprine—systemic scleroderma	0.000562	0.000874	CcSEcCtD
Terazosin—Depression—Methotrexate—systemic scleroderma	0.000562	0.000874	CcSEcCtD
Terazosin—Headache—Azathioprine—systemic scleroderma	0.000559	0.00087	CcSEcCtD
Terazosin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000869	CcSEcCtD
Terazosin—Dizziness—Leflunomide—systemic scleroderma	0.000557	0.000867	CcSEcCtD
Terazosin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000551	0.000858	CcSEcCtD
Terazosin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00055	0.000856	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000548	0.000852	CcSEcCtD
Terazosin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000542	0.000844	CcSEcCtD
Terazosin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000542	0.000844	CcSEcCtD
Terazosin—Arrhythmia—Prednisone—systemic scleroderma	0.000541	0.000841	CcSEcCtD
Terazosin—Sweating—Methotrexate—systemic scleroderma	0.00054	0.00084	CcSEcCtD
Terazosin—Vomiting—Leflunomide—systemic scleroderma	0.000536	0.000833	CcSEcCtD
Terazosin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000533	0.00083	CcSEcCtD
Terazosin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000531	0.000827	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—systemic scleroderma	0.000531	0.000827	CcSEcCtD
Terazosin—Rash—Leflunomide—systemic scleroderma	0.000531	0.000827	CcSEcCtD
Terazosin—Dermatitis—Leflunomide—systemic scleroderma	0.000531	0.000826	CcSEcCtD
Terazosin—Nausea—Azathioprine—systemic scleroderma	0.00053	0.000825	CcSEcCtD
Terazosin—Headache—Leflunomide—systemic scleroderma	0.000528	0.000821	CcSEcCtD
Terazosin—Malnutrition—Prednisone—systemic scleroderma	0.000527	0.00082	CcSEcCtD
Terazosin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000523	0.000813	CcSEcCtD
Terazosin—Asthenia—Lisinopril—systemic scleroderma	0.000519	0.000808	CcSEcCtD
Terazosin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000519	0.000807	CcSEcCtD
Terazosin—Pruritus—Lisinopril—systemic scleroderma	0.000512	0.000797	CcSEcCtD
Terazosin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000511	0.000795	CcSEcCtD
Terazosin—Rash—Mycophenolic acid—systemic scleroderma	0.000507	0.000789	CcSEcCtD
Terazosin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000506	0.000788	CcSEcCtD
Terazosin—Headache—Mycophenolic acid—systemic scleroderma	0.000503	0.000783	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—systemic scleroderma	0.000502	0.000781	CcSEcCtD
Terazosin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00078	CcSEcCtD
Terazosin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00078	CcSEcCtD
Terazosin—Nausea—Leflunomide—systemic scleroderma	0.0005	0.000779	CcSEcCtD
Terazosin—Vision blurred—Prednisone—systemic scleroderma	0.000496	0.000773	CcSEcCtD
Terazosin—Diarrhoea—Lisinopril—systemic scleroderma	0.000495	0.000771	CcSEcCtD
Terazosin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000489	0.000761	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—systemic scleroderma	0.000487	0.000758	CcSEcCtD
Terazosin—Angioedema—Prednisone—systemic scleroderma	0.000481	0.000749	CcSEcCtD
Terazosin—Dizziness—Lisinopril—systemic scleroderma	0.000479	0.000745	CcSEcCtD
Terazosin—Nausea—Mycophenolic acid—systemic scleroderma	0.000477	0.000743	CcSEcCtD
Terazosin—Malaise—Prednisone—systemic scleroderma	0.000475	0.000739	CcSEcCtD
Terazosin—Vertigo—Prednisone—systemic scleroderma	0.000473	0.000736	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—systemic scleroderma	0.000473	0.000735	CcSEcCtD
Terazosin—Syncope—Prednisone—systemic scleroderma	0.000472	0.000735	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—systemic scleroderma	0.000471	0.000734	CcSEcCtD
Terazosin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000727	CcSEcCtD
Terazosin—Loss of consciousness—Prednisone—systemic scleroderma	0.000463	0.00072	CcSEcCtD
Terazosin—Vomiting—Lisinopril—systemic scleroderma	0.00046	0.000716	CcSEcCtD
Terazosin—Rash—Lisinopril—systemic scleroderma	0.000456	0.00071	CcSEcCtD
Terazosin—Convulsion—Prednisone—systemic scleroderma	0.000456	0.00071	CcSEcCtD
Terazosin—Dermatitis—Lisinopril—systemic scleroderma	0.000456	0.00071	CcSEcCtD
Terazosin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000708	CcSEcCtD
Terazosin—Headache—Lisinopril—systemic scleroderma	0.000453	0.000706	CcSEcCtD
Terazosin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000698	CcSEcCtD
Terazosin—Arthralgia—Prednisone—systemic scleroderma	0.000448	0.000698	CcSEcCtD
Terazosin—Myalgia—Prednisone—systemic scleroderma	0.000448	0.000698	CcSEcCtD
Terazosin—Anxiety—Prednisone—systemic scleroderma	0.000447	0.000695	CcSEcCtD
Terazosin—Discomfort—Prednisone—systemic scleroderma	0.000443	0.000689	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—systemic scleroderma	0.00044	0.000685	CcSEcCtD
Terazosin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000675	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—systemic scleroderma	0.000431	0.000671	CcSEcCtD
Terazosin—Nausea—Lisinopril—systemic scleroderma	0.00043	0.000669	CcSEcCtD
Terazosin—Oedema—Prednisone—systemic scleroderma	0.00043	0.000669	CcSEcCtD
Terazosin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00043	0.000669	CcSEcCtD
Terazosin—Back pain—Methotrexate—systemic scleroderma	0.000426	0.000663	CcSEcCtD
Terazosin—Shock—Prednisone—systemic scleroderma	0.000423	0.000658	CcSEcCtD
Terazosin—Tachycardia—Prednisone—systemic scleroderma	0.00042	0.000653	CcSEcCtD
Terazosin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000653	CcSEcCtD
Terazosin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000416	0.000647	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—systemic scleroderma	0.000415	0.000646	CcSEcCtD
Terazosin—Anorexia—Prednisone—systemic scleroderma	0.00041	0.000638	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000408	0.000636	CcSEcCtD
Terazosin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000403	0.000628	CcSEcCtD
Terazosin—Rash—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000622	CcSEcCtD
Terazosin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000622	CcSEcCtD
Terazosin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000618	CcSEcCtD
Terazosin—Malaise—Methotrexate—systemic scleroderma	0.000397	0.000618	CcSEcCtD
Terazosin—Vertigo—Methotrexate—systemic scleroderma	0.000395	0.000615	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000392	0.00061	CcSEcCtD
Terazosin—Insomnia—Prednisone—systemic scleroderma	0.000389	0.000605	CcSEcCtD
Terazosin—Paraesthesia—Prednisone—systemic scleroderma	0.000386	0.000601	CcSEcCtD
Terazosin—Cough—Methotrexate—systemic scleroderma	0.000384	0.000598	CcSEcCtD
Terazosin—Convulsion—Methotrexate—systemic scleroderma	0.000381	0.000594	CcSEcCtD
Terazosin—Dyspepsia—Prednisone—systemic scleroderma	0.000378	0.000589	CcSEcCtD
Terazosin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000586	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—systemic scleroderma	0.000375	0.000583	CcSEcCtD
Terazosin—Myalgia—Methotrexate—systemic scleroderma	0.000375	0.000583	CcSEcCtD
Terazosin—Chest pain—Methotrexate—systemic scleroderma	0.000375	0.000583	CcSEcCtD
Terazosin—Decreased appetite—Prednisone—systemic scleroderma	0.000374	0.000582	CcSEcCtD
Terazosin—Fatigue—Prednisone—systemic scleroderma	0.000371	0.000577	CcSEcCtD
Terazosin—Discomfort—Methotrexate—systemic scleroderma	0.00037	0.000576	CcSEcCtD
Terazosin—Constipation—Prednisone—systemic scleroderma	0.000368	0.000572	CcSEcCtD
Terazosin—Confusional state—Methotrexate—systemic scleroderma	0.000362	0.000564	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000359	0.000559	CcSEcCtD
Terazosin—Feeling abnormal—Prednisone—systemic scleroderma	0.000354	0.000551	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000352	0.000547	CcSEcCtD
Terazosin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000352	0.000547	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000347	0.00054	CcSEcCtD
Terazosin—Anorexia—Methotrexate—systemic scleroderma	0.000342	0.000533	CcSEcCtD
Terazosin—Body temperature increased—Prednisone—systemic scleroderma	0.00034	0.000529	CcSEcCtD
Terazosin—Abdominal pain—Prednisone—systemic scleroderma	0.00034	0.000529	CcSEcCtD
Terazosin—Hypotension—Methotrexate—systemic scleroderma	0.000336	0.000522	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000327	0.000509	CcSEcCtD
Terazosin—Insomnia—Methotrexate—systemic scleroderma	0.000325	0.000506	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—systemic scleroderma	0.000323	0.000502	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—systemic scleroderma	0.00032	0.000498	CcSEcCtD
Terazosin—Somnolence—Methotrexate—systemic scleroderma	0.000319	0.000497	CcSEcCtD
Terazosin—Hypersensitivity—Prednisone—systemic scleroderma	0.000317	0.000493	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—systemic scleroderma	0.000316	0.000492	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—systemic scleroderma	0.000312	0.000486	CcSEcCtD
Terazosin—Fatigue—Methotrexate—systemic scleroderma	0.00031	0.000482	CcSEcCtD
Terazosin—Asthenia—Prednisone—systemic scleroderma	0.000308	0.00048	CcSEcCtD
Terazosin—Pain—Methotrexate—systemic scleroderma	0.000307	0.000478	CcSEcCtD
Terazosin—Pruritus—Prednisone—systemic scleroderma	0.000304	0.000473	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000296	0.000461	CcSEcCtD
Terazosin—Diarrhoea—Prednisone—systemic scleroderma	0.000294	0.000458	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000294	0.000457	CcSEcCtD
Terazosin—Dizziness—Prednisone—systemic scleroderma	0.000284	0.000442	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—systemic scleroderma	0.000284	0.000442	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—systemic scleroderma	0.000284	0.000442	CcSEcCtD
Terazosin—Vomiting—Prednisone—systemic scleroderma	0.000273	0.000425	CcSEcCtD
Terazosin—Rash—Prednisone—systemic scleroderma	0.000271	0.000422	CcSEcCtD
Terazosin—Dermatitis—Prednisone—systemic scleroderma	0.000271	0.000421	CcSEcCtD
Terazosin—Headache—Prednisone—systemic scleroderma	0.000269	0.000419	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000265	0.000412	CcSEcCtD
Terazosin—Asthenia—Methotrexate—systemic scleroderma	0.000258	0.000401	CcSEcCtD
Terazosin—Nausea—Prednisone—systemic scleroderma	0.000255	0.000397	CcSEcCtD
Terazosin—Pruritus—Methotrexate—systemic scleroderma	0.000254	0.000396	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—systemic scleroderma	0.000246	0.000383	CcSEcCtD
Terazosin—Dizziness—Methotrexate—systemic scleroderma	0.000238	0.00037	CcSEcCtD
Terazosin—Vomiting—Methotrexate—systemic scleroderma	0.000228	0.000355	CcSEcCtD
Terazosin—Rash—Methotrexate—systemic scleroderma	0.000227	0.000353	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—systemic scleroderma	0.000226	0.000352	CcSEcCtD
Terazosin—Headache—Methotrexate—systemic scleroderma	0.000225	0.00035	CcSEcCtD
Terazosin—Nausea—Methotrexate—systemic scleroderma	0.000213	0.000332	CcSEcCtD
